Search - tctmd.com

Displaying 481 - 500 of 626

Sort: Relevancy | Date

News Daily News

NHANES: Just Over Half of Eligible Patients Taking Cholesterol-Lowering Medication

Michael O'Riordan

December 08, 2015

News Conference News VEITH 2015

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

Yael L. Maxwell

November 19, 2015

News Industry News

CVRx® Announces Expedited Access Pathway Designation By FDA for Barostim Therapy® for the Treatment Of Heart Failure In Order To Accelerate Access for US Patients

November 18, 2015

News Industry News

Resverlogix Commences Phase 3 Clinical Trial BETonMACE With Apabetalone

October 26, 2015

News Conference News TCT 2015

EXPLORE: Treating CTOs After STEMI Does Not Improve LV Function

Todd Neale

October 13, 2015

News Industry News

Medical Therapy With Ranolazine Did Not Reduce Adverse Events In Patients With Persistent Untreated Heart Artery Blockages After Percutaneous Coronary Intervention

October 13, 2015

News Conference News TCT 2015

First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible

October 12, 2015

News Conference News TCT 2015

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Yael L. Maxwell

October 12, 2015

News Industry News

Scripps experts present at 2015 TCT scientific symposium

October 09, 2015

News Daily News

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

September 22, 2015

News Industry News

Medtronic First to Receive FDA Approval for MR-Conditional Implantable Cardioverter Defibrillator System

September 15, 2015

News Industry News

HeartStitch® Brings New Technology to Astana to Treat Structural Heart Disease

September 11, 2015

News Conference News ESC 2015

CIRCUS: Transplant Rejection Drug Fails to Reduce Infarct Size in Anterior STEMI

L.A. McKeown

August 30, 2015

News Industry News

FDA approves Repatha to treat certain patients with high cholesterol

August 28, 2015

News Daily News

CoreValve US Subanalysis: Only Femoral TAVR Offers Early QoL Advantage Over Surgery

L.A. McKeown

August 19, 2015

News Industry News

Doctor's Best Introduces Two New Heart Health Supplements

August 11, 2015

News Daily News

Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin

L.A. McKeown

July 29, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Daily News

Statement on LAA Closure Highlights Key Issues for Growing Field

July 02, 2015

News Industry News

SentreHEART Receives FDA Approval for the AMAZE Trial to Evaluate LARIAT Ligation of the Left Atrial

June 29, 2015

Advertisement

NHANES: Just Over Half of Eligible Patients Taking Cholesterol-Lowering Medication

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

CVRx® Announces Expedited Access Pathway Designation By FDA for Barostim Therapy® for the Treatment Of Heart Failure In Order To Accelerate Access for US Patients

Resverlogix Commences Phase 3 Clinical Trial BETonMACE With Apabetalone

EXPLORE: Treating CTOs After STEMI Does Not Improve LV Function

Medical Therapy With Ranolazine Did Not Reduce Adverse Events In Patients With Persistent Untreated Heart Artery Blockages After Percutaneous Coronary Intervention

First-in-Human Studies: Novel Devices for Aortic Valve Stenosis Safe, Feasible

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Scripps experts present at 2015 TCT scientific symposium

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

Medtronic First to Receive FDA Approval for MR-Conditional Implantable Cardioverter Defibrillator System

HeartStitch® Brings New Technology to Astana to Treat Structural Heart Disease

CIRCUS: Transplant Rejection Drug Fails to Reduce Infarct Size in Anterior STEMI

FDA approves Repatha to treat certain patients with high cholesterol

CoreValve US Subanalysis: Only Femoral TAVR Offers Early QoL Advantage Over Surgery

Doctor's Best Introduces Two New Heart Health Supplements

Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Statement on LAA Closure Highlights Key Issues for Growing Field

SentreHEART Receives FDA Approval for the AMAZE Trial to Evaluate LARIAT Ligation of the Left Atrial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content